| Ken, a molecular biologist by training, has over 23 years experience in the biotech field. His commercial experience began through several highly successful start-up biotech companies including Qiagen which he joined in its first year of operations. Prior to starting Toti Ken managed Pall Corporation’s global biosciences division, a $170 million business which focused on consumables for the research, quality control validation, medical device and stem cell marketplace. |
|
Mitchel, a cell biologist by training, has extensive experience in the development and launch of disposable cell therapy devices. Prior to starting Toti, he served as the global program manager of cord blood cell therapy at Pall Corporation – a role in which he was directly responsible for stem cell purification technologies and the launch of a specialized collection system designed for both caesarian sections and natural births. Mitchel has supported cord blood, advanced tissue banking and stem cell translational facilities in over 15 countries from research through clinical applications. |
|
Venkatesh, a medical immunologist, has over twenty five internationally recognized publications in the role of cellular and cytokine mediated inflammatory response. Dr. Ponemone completed his post doctoral training at the University of Illinois at Chicago, and also holds a certified clinical research professional designation. Prior to joining Toti, he served as Assistant Professor at Kameneni Institute of Medical Sciences, Narkatpalli. |
